Basel Medical Group Ltd
BMGL
$0.77
-$0.09-10.37%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 3.73% | 23.44% | |||
| Total Other Revenue | 3.73% | 11,472.00% | |||
| Total Revenue | 3.72% | 38.58% | |||
| Cost of Revenue | 3.73% | 27.53% | |||
| Gross Profit | 3.73% | 76.18% | |||
| SG&A Expenses | 3.71% | 421.56% | |||
| Depreciation & Amortization | 3.70% | 133.46% | |||
| Other Operating Expenses | 3.72% | -0.92% | |||
| Total Operating Expenses | 3.73% | 36.29% | |||
| Operating Income | -3.75% | -16.04% | |||
| Income Before Tax | -3.73% | -3,704.80% | |||
| Income Tax Expenses | -3.74% | -155,000.00% | |||
| Earnings from Continuing Operations | -3.72% | -3,571.32% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 0.00% | -- | |||
| Net Income | -3.73% | -3,571.15% | |||
| EBIT | -3.75% | -16.04% | |||
| EBITDA | -3.71% | -4.66% | |||
| EPS Basic | -3.71% | -2,704.11% | |||
| Normalized Basic EPS | -4.42% | -145.65% | |||
| EPS Diluted | -3.71% | -2,704.11% | |||
| Normalized Diluted EPS | -4.42% | -145.65% | |||
| Average Basic Shares Outstanding | 0.00% | 31.21% | |||
| Average Diluted Shares Outstanding | 0.00% | 31.21% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||